Bullish option flow detected in Crispr Therapeutics (CRSP) with 5,198 calls trading, 1.3x expected, and implied vol increasing over 3 points to 55.13%. Jan-25 50 calls and Dec-24 47 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.20. Earnings are expected on February 19th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Crispr Therapeutics presents data on CTX112 at ASH Meeting
- Biotech Alert: Searches spiking for these stocks today
- CRISPR Therapeutics (NASDAQ:CRSP) Boasts Solid Potential and Limited Risk
- Cathie Wood’s ARK Investment bought 176K shares of Crispr Therapeutics today
- Crispr Therapeutics management to meet with Piper Sandler